Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples